Single-Use Bioreactors Market by Product, Type, Cell Type, Molecule, Process Mode, Application, Competition, Region

Description

List of Tables

The single-use bioreactors market is projected to reach USD 9.58 billion by 2031 from an estimated USD 5.43 billion in 2026, at a CAGR of 12.0% during the forecast period of 2026 to 2031. Market growth is primarily supported by expanding biologics and biosimilar production, rising vaccine manufacturing, increasing outsourcing to CDMOs, and greater adoption of flexible bioprocessing technologies.

Scope of the Report
Years Considered for the Study	2026-2031
Base Year	2025
Forecast Period	2026-2031
Units Considered	Value (USD billion)
Segments	Product, Type, Cell Type, Process Mode, Molecule Type, Application, End User
Regions covered	North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

The growing use of single-use systems in monoclonal antibody, recombinant protein, viral vector, and cell & gene therapy manufacturing is further accelerating demand. Their lower capital requirements, reduced cleaning validation, faster product changeovers, and suitability for multiproduct facilities are expected to support market expansion.

By application, the bioproduction segment accounted for the largest share of the market in 2025.

In 2025, the bioproduction segment accounted for the largest share of the global single-use bioreactors market. These systems are extensively used for the commercial and clinical production of monoclonal antibodies, vaccines, recombinant proteins, biosimilars, viral vectors, and other biologics. The segment's leading position is supported by increasing demand for biologics, expansion of global manufacturing capacity, and growing adoption of scalable single-use platforms across pharmaceutical and biotechnology companies and CDMOs. Their ability to reduce contamination risks, shorten turnaround times, and support batch, fed-batch, and perfusion processes further strengthens their use in bioproduction applications.

The monoclonal antibodies segment accounted for a major share of the single-use bioreactors market in 2025.

The single-use bioreactors market is categorized by molecule type into monoclonal antibodies, vaccines, cell & gene therapy, and therapeutic proteins & peptides. The monoclonal antibodies segment accounted for the largest market share in 2025, supported by the substantial number of approved products, extensive development pipelines, and continued expansion of commercial manufacturing capacity. Monoclonal antibody production requires scalable and tightly controlled mammalian cell culture processes, creating sustained demand for stirred-tank single-use bioreactors, bags, assemblies, sensors, and fluid-management components. Their suitability for batch, fed-batch, and intensified processing further supports adoption across pharmaceutical and biotechnology companies and CDMOs.

The Asia Pacific region is expected to experience the highest CAGR in the single-use bioreactors market from 2026 to 2031.

The single-use bioreactors market is divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Asia Pacific is expected to register the fastest growth during the forecast period, driven by expanding biologics and biosimilar production, increasing vaccine manufacturing, rising CDMO capacity, and greater investment in domestic biopharmaceutical infrastructure. China, India, Japan, South Korea, and Australia are strengthening their upstream processing capabilities through new facilities, capacity additions, and wider adoption of modular and flexible production technologies. Government support for local manufacturing and the growth of cell & gene therapy activity are further accelerating regional demand.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side (80%) and Demand Side (20%)
By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%)
By Region: North America (40%), Europe (25%), Asia Pacific (25%), Latin America (5%), and the Middle East & Africa (5%)

Sartorius AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Avantor, Inc. (US), Repligen Corporation (US), Getinge AB (Sweden), Eppendorf SE (Germany), Parker Hannifin Corporation (US), Entegris (US), Saint-Gobain (France), Corning Incorporated (US), Lonza (Switzerland), TECNIC Process Equipment Manufacturing, S.L. (Spain), ZACROS Corporation (Japan), Adolf Kuhner AG (Switzerland), OmniBRx Biotechnologies Pvt Ltd. (India), New Horizon Biotechnology, Inc. (US), PBS Biotech, Inc. (US), bbi-biotech GmbH (Germany), ABEC, Inc. (US), Esco Lifesciences Group (US), Distek, Inc. (US), SATAKE MultiMix Corporation (Japan), Cell Culture Company, LLC (US), MicroDigital Co., Ltd. (South Korea), BIONET (Spain), Meissner Filtration Products, Inc. (US), Solida Biotech GmbH (Germany), G&G Technologies, Inc. (US), PharmNXT Biotech (India), and Tofflon Life Science Co., Ltd. (China) are some of the key companies offering single-use bioreactors solutions.

Research Coverage

This research report categorizes the single-use bioreactors market by product (single-use bioreactor systems, single-use bags, single-use assemblies, and other products), type (stirred-tank single-use bioreactors, wave-induced single-use bioreactors, fixed-bed single-use bioreactors, bubble-column single-use bioreactors, and other single-use bioreactors), cell type (mammalian cells, bacterial cells, yeast cells, and other cells), molecule type (monoclonal antibodies, vaccines, cell & gene therapy, and therapeutic proteins & peptides), process mode (fed-batch, batch, and perfusion/continuous), application (bioproduction, process development, and research & development), end user (pharmaceutical and biotechnology companies, CROs & CMOs, and academic & research institutes), and region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).

The scope of the report provides detailed information on major factors such as drivers, challenges, opportunities, and restraints that influence the growth of the single-use bioreactors market. A comprehensive analysis of key industry players has been conducted to provide insights into their business overviews, product portfolios, and key strategies, including collaborations, partnerships, expansions, agreements, acquisitions, and recent developments in the single-use bioreactors market.

Key Benefits of Buying the Report

This report offers a comprehensive overview of the single-use bioreactors market. It aims to assess the market size and future growth opportunities across various segments. The report also features an in-depth competitive analysis of the major market players, including their company profiles, recent developments, and key market strategies

The report provides insights into the following pointers:

Analysis of key drivers (rising adoption of flexible sub platforms among CDMOs, CMOs, and SMEs, operational advantages over conventional bioreactors, reduced upfront capital investment, reduced water and energy consumption, and expansion of biologics and biosimilar manufacturing demand), restraints (concerns related to extractables and leachables, regulatory and compliance requirements for SUB implementation, and impact of PFAS restrictions on product development), opportunities (untapped growth potential in emerging biomanufacturing economies and shift toward hybrid biomanufacturing), and challenges (lack of standardization, waste disposal burden and sustainability pressure, and risk of SU bag leakage and integrity failure) influencing the growth of the market.
Product Development/Innovation: Detailed insights on newly launched products of the single-use bioreactors market.
Market Development: Comprehensive information about lucrative markets; the report analyzes the market across varied regions.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the single-use bioreactors market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Sartorius AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Avantor, Inc. (US), Repligen Corporation (US), Getinge AB (Sweden), Eppendorf SE (Germany), Parker Hannifin Corporation (US), Entegris (US), Saint-Gobain (France), Corning Incorporated (US), Lonza (Switzerland), TECNIC Process Equipment Manufacturing, S.L. (Spain), ZACROS Corporation (Japan), Adolf Kuhner AG (Switzerland), OmniBRx Biotechnologies Pvt Ltd. (India), New Horizon Biotechnology, Inc. (US), PBS Biotech, Inc. (US), bbi-biotech GmbH (Germany), ABEC, Inc. (US), Esco Lifesciences Group (US), Distek, Inc. (US), SATAKE MultiMix Corporation (Japan), Cell Culture Company, LLC (US), MicroDigital Co., Ltd. (South Korea), BIONET (Spain), Meissner Filtration Products, Inc. (US), Solida Biotech GmbH (Germany), G&G Technologies, Inc. (US), PharmNXT Biotech (India), and Tofflon Life Science Co., Ltd. (China).

Product Code: BT 2863

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION & REGIONS COVERED
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

2.1 MARKET HIGHLIGHTS & KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN SINGLE-USE BIOREACTORS MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

3.1 GLOBAL SINGLE-USE BIOREACTORS MARKET SNAPSHOT
3.2 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT AND COUNTRY, 2025
3.3 SINGLE-USE BIOREACTORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
3.4 SINGLE-USE BIOREACTORS MARKET SHARE, BY END USER, 2026 VS. 2031 (%)

4 MARKET OVERVIEW

4.1 INTRODUCTION
4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
  - 4.2.1.1 Rising adoption of flexible SUB platforms among CDMOs, CMOs, and SMEs
  - 4.2.1.2 Operational advantages over conventional bioreactors
  - 4.2.1.3 Reduced upfront capital investment
  - 4.2.1.4 Reduced water and energy consumption
  - 4.2.1.5 Expansion of biologics and biosimilar manufacturing demand
- 4.2.2 RESTRAINTS
  - 4.2.2.1 Concerns related to extractables and leachables
  - 4.2.2.2 Regulatory and compliance requirements for SUB implementation
  - 4.2.2.3 Impact of PFAS restrictions on product development
- 4.2.3 OPPORTUNITIES
  - 4.2.3.1 Untapped growth potential in emerging biomanufacturing economies
  - 4.2.3.2 Shift towards hybrid biomanufacturing
- 4.2.4 CHALLENGES
  - 4.2.4.1 Lack of standardization
  - 4.2.4.2 Waste disposal burden and sustainability pressure
  - 4.2.4.3 Risk of SU bag leakage and integrity failure
4.3 UNMET NEEDS & WHITE SPACES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 BARGAINING POWER OF SUPPLIERS
- 5.1.2 BARGAINING POWER OF BUYERS
- 5.1.3 THREAT OF NEW ENTRANTS
- 5.1.4 THREAT OF SUBSTITUTES
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS & FORECAST
- 5.2.3 TRENDS IN GLOBAL SINGLE-USE BIOREACTORS INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
- 5.5.1 AVERAGE SELLING PRICE TREND OF KEY SINGLE-USE BIOREACTOR PRODUCTS, BY KEY PLAYER, 2023-2025
- 5.5.2 AVERAGE SELLING PRICE TREND OF KEY SINGLE-USE BIOREACTOR PRODUCTS, BY REGION, 2023-2025
5.6 TRADE ANALYSIS
- 5.6.1 IMPORT SCENARIO (HS CODE 841989)
- 5.6.2 EXPORT SCENARIO (HS CODE 841989)
5.7 KEY CONFERENCES & EVENTS, 2026-2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.9 INVESTMENT & FUNDING SCENARIO
- 5.9.1 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
5.10 IMPACT OF 2025 US TARIFFS ON SINGLE-USE BIOREACTORS MARKET
- 5.10.1 INTRODUCTION
- 5.10.2 KEY TARIFF RATES
- 5.10.3 PRICE IMPACT ANALYSIS
- 5.10.4 IMPACT ON COUNTRIES/REGIONS
  - 5.10.4.1 US
  - 5.10.4.2 Europe
  - 5.10.4.3 Asia Pacific
- 5.10.5 IMPACT ON END-USE INDUSTRIES
  - 5.10.5.1 Pharmaceutical & biotechnology companies
  - 5.10.5.2 CROs & CMOs
  - 5.10.5.3 Academic & research institutes

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS

6.1 TECHNOLOGY ANALYSIS
- 6.1.1 KEY EMERGING TECHNOLOGIES
  - 6.1.1.1 Fermentation
  - 6.1.1.2 Continuous bioprocessing
  - 6.1.1.3 3D cell culture
- 6.1.2 COMPLEMENTARY TECHNOLOGIES
  - 6.1.2.1 Automation & control
  - 6.1.2.2 Data analytics & machine learning
- 6.1.3 ADJACENT TECHNOLOGIES
  - 6.1.3.1 Filtration
  - 6.1.3.2 Cell separation
6.2 TECHNOLOGY/PRODUCT ROADMAP
6.3 PATENT ANALYSIS
- 6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR SINGLE-USE BIOREACTOR PATENTS
6.4 FUTURE APPLICATIONS
6.5 IMPACT OF AI/GEN AI ON SINGLE-USE BIOREACTORS MARKET
- 6.5.1 BEST PRACTICES IN SINGLE-USE BIOREACTORS WORKFLOW
- 6.5.2 CASE STUDIES OF AI IMPLEMENTATION IN SINGLE-USE BIOREACTORS MARKET
- 6.5.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
- 6.5.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN SINGLE-USE BIOREACTORS MARKET

7 SUSTAINABILITY & REGULATORY LANDSCAPE

7.1 REGIONAL REGULATIONS & COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.2 REGULATORY FRAMEWORK
  - 7.1.2.1 North America
  - 7.1.2.2 Europe
  - 7.1.2.3 Asia Pacific
  - 7.1.2.4 Rest of the World
- 7.1.3 INDUSTRY STANDARDS
7.2 SUSTAINABILITY INITIATIVES
7.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
- 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.2.2 KEY BUYING CRITERIA, BY END USER
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY

9 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT

9.1 INTRODUCTION
9.2 SINGLE-USE BIOREACTOR SYSTEMS
- 9.2.1 <=10 L BIOREACTORS
  - 9.2.1.1 High-throughput process development and scale-down studies to support market growth
- 9.2.2 11-100 L BIOREACTORS
  - 9.2.2.1 Increasing pilot-scale and clinical manufacturing to support market growth
- 9.2.3 101-500 L BIOREACTORS
  - 9.2.3.1 Flexible scale-up from clinical to early commercial production to propel market growth
- 9.2.4 501-1,500 L BIOREACTORS
  - 9.2.4.1 Expanding late-stage and commercial biologics capacity to support market growth
- 9.2.5 >1,500 L BIOREACTORS
  - 9.2.5.1 Large-scale single-use commercialization to strengthen market position
9.3 SINGLE-USE BAGS
- 9.3.1 2D SINGLE-USE BAGS
  - 9.3.1.1 Low-volume flexibility and expanding cell therapy applications to support market growth
- 9.3.2 3D SINGLE-USE BAGS
  - 9.3.2.1 Large-volume biologics production to support market growth
9.4 SINGLE-USE ASSEMBLIES
- 9.4.1 INCREASING ADOPTION OF CLOSED FLUID PATHS TO SUPPORT MARKET GROWTH
9.5 OTHER PRODUCTS

10 SINGLE-USE BIOREACTORS MARKET, BY TYPE

10.1 INTRODUCTION
10.2 STIRRED-TANK SINGLE-USE BIOREACTORS
- 10.2.1 BROAD SCALABILITY AND COMPATIBILITY WITH INTENSIFIED CELL CULTURE TO SUPPORT MARKET GROWTH
10.3 WAVE-INDUCED SINGLE-USE BIOREACTORS
- 10.3.1 INCREASING ADOPTION IN CELL THERAPY AND SEED-TRAIN APPLICATIONS TO SUPPORT MARKET GROWTH
10.4 FIXED-BED SINGLE-USE BIOREACTORS
- 10.4.1 HIGH-DENSITY ADHERENT CELL AND VIRAL VECTOR PRODUCTION TO DRIVE FASTEST MARKET GROWTH
10.5 BUBBLE-COLUMN SINGLE-USE BIOREACTORS
- 10.5.1 IMPELLER-FREE MIXING AND EXPANDING MICROBIAL APPLICATIONS TO SUPPORT MARKET GROWTH
10.6 OTHER SINGLE-USE BIOREACTORS

11 SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE

11.1 INTRODUCTION
11.2 MONOCLONAL ANTIBODIES
- 11.2.1 EXPANDING THERAPEUTIC PIPELINES AND BIOSIMILAR PRODUCTION TO SUPPORT SEGMENT DOMINANCE
11.3 VACCINES
- 11.3.1 EXPANDING VACCINE PIPELINES AND FLEXIBLE MANUFACTURING REQUIREMENTS TO SUPPORT MARKET GROWTH
11.4 CELL & GENE THERAPY
- 11.4.1 EXPANDING ADVANCED THERAPY PIPELINES AND MANUFACTURING INVESTMENTS TO SUPPORT MARKET GROWTH
11.5 THERAPEUTIC PROTEINS & PEPTIDES
- 11.5.1 INCREASING DEMAND FOR RECOMBINANT PROTEINS AND PEPTIDE THERAPEUTICS TO SUPPORT MARKET GROWTH

12 SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE

12.1 INTRODUCTION
12.2 MAMMALIAN CELLS
- 12.2.1 HIGH DEMAND FOR COMPLEX BIOLOGICS TO SUPPORT SEGMENT DOMINANCE
12.3 BACTERIAL CELLS
- 12.3.1 EXPANDING PLASMID DNA AND RECOMBINANT PROTEIN PRODUCTION TO SUPPORT MARKET GROWTH
12.4 YEAST CELLS
- 12.4.1 INCREASING USE IN RECOMBINANT PROTEIN AND VACCINE PRODUCTION TO SUPPORT MARKET GROWTH
12.5 OTHER CELLS

13 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION

13.1 INTRODUCTION
13.2 BIOPRODUCTION
- 13.2.1 COMMERCIAL BIOLOGICS PRODUCTION AND FLEXIBLE MANUFACTURING CAPACITY TO REINFORCE SEGMENT LEADERSHIP
13.3 PROCESS DEVELOPMENT
- 13.3.1 ACCELERATED PROCESS OPTIMIZATION TO DRIVE GROWTH OF PROCESS DEVELOPMENT APPLICATIONS
13.4 RESEARCH & DEVELOPMENT
- 13.4.1 GROWING ADOPTION OF INTENSIFIED BIOPROCESSING TO DRIVE FASTEST GROWTH IN PERFUSION-BASED MANUFACTURING

14 SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE

14.1 INTRODUCTION
14.2 FED-BATCH PROCESS MODE
- 14.2.1 COMMERCIAL BIOLOGICS MANUFACTURING TO CONTINUE TO POSITION FED-BATCH AS LARGEST PROCESS SEGMENT
14.3 BATCH PROCESS MODE
- 14.3.1 PROCESS DEVELOPMENT AND SMALL-SCALE BIOLOGICS PRODUCTION TO SUSTAIN DEMAND FOR BATCH PROCESSING
14.4 PERFUSION/CONTINUOUS PROCESS MODE
- 14.4.1 GROWING ADOPTION OF INTENSIFIED BIOPROCESSING TO DRIVES FASTEST GROWTH IN PERFUSION-BASED MANUFACTURING

15 SINGLE-USE BIOREACTORS MARKET, BY END USER

15.1 INTRODUCTION
15.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 15.2.1 COMMERCIAL BIOLOGICS PRODUCTION AND FLEXIBLE MANUFACTURING CAPACITY TO REINFORCE SEGMENT LEADERSHIP
15.3 CROS & CDMOS
- 15.3.1 BIOLOGICS OUTSOURCING TO DRIVE GROWTH AMONG CROS AND CMOS
15.4 ACADEMIC & RESEARCH INSTITUTES
- 15.4.1 EXPANDING LIFE SCIENCE RESEARCH TO CONTINUE TO SUPPORT DEMAND FROM ACADEMIC & RESEARCH INSTITUTES

16 SINGLE-USE BIOREACTORS MARKET, BY REGION

16.1 INTRODUCTION
16.2 NORTH AMERICA
- 16.2.1 US
  - 16.2.1.1 US to dominate North American market during study period
- 16.2.2 CANADA
  - 16.2.2.1 Public bio-manufacturing investment and advanced-therapy capacity expansion to support market growth
16.3 EUROPE
- 16.3.1 GERMANY
  - 16.3.1.1 Strong bioprocessing ecosystem and expanding therapeutic pipelines to support market growth
- 16.3.2 UK
  - 16.3.2.1 Public funding and advanced-therapy manufacturing to support market growth
- 16.3.3 FRANCE
  - 16.3.3.1 Strong bioprocessing supply base and biopharmaceutical investments to support market growth
- 16.3.4 ITALY
  - 16.3.4.1 Strong pharmaceutical manufacturing and advanced-therapy capabilities to support market growth
- 16.3.5 SPAIN
  - 16.3.5.1 Expanding biotechnology R&D and CDMO capacity to support market growth
- 16.3.6 REST OF EUROPE
16.4 ASIA PACIFIC
- 16.4.1 CHINA
  - 16.4.1.1 Large biologics pipeline and commercial-scale single-use capacity to drive market growth
- 16.4.2 SOUTH KOREA
  - 16.4.2.1 Large-scale CDMO capacity and export-oriented biopharmaceutical industry to support market growth
- 16.4.3 JAPAN
  - 16.4.3.1 Biologics pipeline expansion and regenerative medicine commercialization to support market growth
- 16.4.4 INDIA
  - 16.4.4.1 Export-oriented biopharmaceutical industry and policy support to drive market growth
- 16.4.5 AUSTRALIA
  - 16.4.5.1 Clinical research funding and advanced-therapy manufacturing to support market growth
- 16.4.6 REST OF ASIA PACIFIC
16.5 LATIN AMERICA
- 16.5.1 BRAZIL
  - 16.5.1.1 Public bioproduction investment and expanding vaccine capabilities to support market growth
- 16.5.2 MEXICO
  - 16.5.2.1 Domestic biopharmaceutical capacity expansion to support market growth
- 16.5.3 REST OF LATIN AMERICA
16.6 MIDDLE EAST
- 16.6.1 GCC COUNTRIES
  - 16.6.1.1 Saudi Arabia
    - 16.6.1.1.1 National biotechnology strategy and commercial biopharma capacity to propel market growth
  - 16.6.1.2 UAE
    - 16.6.1.2.1 Vaccine manufacturing and regulatory ecosystem development to support market growth
  - 16.6.1.3 Rest of GCC countries
- 16.6.2 REST OF MIDDLE EAST
16.7 AFRICA
- 16.7.1 VACCINE MANUFACTURING LOCALIZATION AND TECHNOLOGY TRANSFER TO SUPPORT MARKET GROWTH

17 COMPETITIVE LANDSCAPE

17.1 OVERVIEW
17.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 17.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SINGLE-USE BIOREACTORS MARKET
17.3 REVENUE ANALYSIS, 2021-2025
17.4 MARKET SHARE ANALYSIS, 2025
17.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 17.5.1 STARS
- 17.5.2 EMERGING LEADERS
- 17.5.3 PERVASIVE PLAYERS
- 17.5.4 PARTICIPANTS
- 17.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
  - 17.5.5.1 Company footprint
  - 17.5.5.2 Region footprint
  - 17.5.5.3 Product footprint
  - 17.5.5.4 Type footprint
  - 17.5.5.5 Application footprint
17.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 17.6.1 PROGRESSIVE COMPANIES
- 17.6.2 RESPONSIVE COMPANIES
- 17.6.3 DYNAMIC COMPANIES
- 17.6.4 STARTING BLOCKS
- 17.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
  - 17.6.5.1 Detailed list of key startups/SMEs
  - 17.6.5.2 Competitive benchmarking of key startups/SMEs
17.7 COMPANY VALUATION & FINANCIAL METRICS
- 17.7.1 FINANCIAL METRICS
- 17.7.2 COMPANY VALUATION
17.8 BRAND/PRODUCT COMPARISON
17.9 COMPETITIVE SCENARIO
- 17.9.1 PRODUCT LAUNCHES
- 17.9.2 DEALS
- 17.9.3 EXPANSIONS

18 COMPANY PROFILES

18.1 KEY PLAYERS
- 18.1.1 SARTORIUS AG
  - 18.1.1.1 Business overview
  - 18.1.1.2 Products offered
  - 18.1.1.3 Recent developments
    - 18.1.1.3.1 Product launches
    - 18.1.1.3.2 Deals
    - 18.1.1.3.3 Expansions
  - 18.1.1.4 MnM view
    - 18.1.1.4.1 Key strengths
    - 18.1.1.4.2 Strategic choices
    - 18.1.1.4.3 Weaknesses & competitive threats
- 18.1.2 DANAHER CORPORATION
  - 18.1.2.1 Business overview
  - 18.1.2.2 Products offered
  - 18.1.2.3 Recent developments
    - 18.1.2.3.1 Product launches
    - 18.1.2.3.2 Deals
    - 18.1.2.3.3 Expansions
  - 18.1.2.4 MnM view
    - 18.1.2.4.1 Right to win
    - 18.1.2.4.2 Strategic choices
    - 18.1.2.4.3 Weaknesses & competitive threats
- 18.1.3 THERMO FISHER SCIENTIFIC INC.
  - 18.1.3.1 Business overview
  - 18.1.3.2 Products offered
  - 18.1.3.3 Recent developments
    - 18.1.3.3.1 Product launches
    - 18.1.3.3.2 Deals
    - 18.1.3.3.3 Expansions
  - 18.1.3.4 MnM view
    - 18.1.3.4.1 Right to win
    - 18.1.3.4.2 Strategic choices
    - 18.1.3.4.3 Weaknesses & competitive threats
- 18.1.4 MERCK KGAA
  - 18.1.4.1 Business overview
  - 18.1.4.2 Products offered
  - 18.1.4.3 Recent developments
    - 18.1.4.3.1 Product launches
    - 18.1.4.3.2 Deals
    - 18.1.4.3.3 Expansions
  - 18.1.4.4 MnM view
    - 18.1.4.4.1 Right to win
    - 18.1.4.4.2 Strategic choices
    - 18.1.4.4.3 Weaknesses & competitive threats
- 18.1.5 AVANTOR, INC.
  - 18.1.5.1 Business overview
  - 18.1.5.2 Products offered
  - 18.1.5.3 Recent developments
    - 18.1.5.3.1 Deals
    - 18.1.5.3.2 Expansions
- 18.1.6 REPLIGEN CORPORATION
  - 18.1.6.1 Business overview
  - 18.1.6.2 Products offered
  - 18.1.6.3 Recent developments
    - 18.1.6.3.1 Deals
    - 18.1.6.3.2 Expansions
- 18.1.7 GETINGE AB
  - 18.1.7.1 Business overview
  - 18.1.7.2 Products offered
  - 18.1.7.3 Recent developments
    - 18.1.7.3.1 Product launches
    - 18.1.7.3.2 Deals
    - 18.1.7.3.3 Expansions
- 18.1.8 EPPENDORF SE
  - 18.1.8.1 Business overview
  - 18.1.8.2 Products offered
  - 18.1.8.3 Recent developments
    - 18.1.8.3.1 Deals
    - 18.1.8.3.2 Expansions
- 18.1.9 PARKER HANNIFIN CORPORATION
  - 18.1.9.1 Business overview
  - 18.1.9.2 Products offered
- 18.1.10 ENTEGRIS
  - 18.1.10.1 Business overview
  - 18.1.10.2 Products offered
- 18.1.11 SAINT-GOBAIN
  - 18.1.11.1 Business overview
  - 18.1.11.2 Products offered
  - 18.1.11.3 Recent developments
    - 18.1.11.3.1 Product launches
    - 18.1.11.3.2 Expansions
- 18.1.12 CORNING INCORPORATED
  - 18.1.12.1 Business overview
  - 18.1.12.2 Products offered
- 18.1.13 LONZA
  - 18.1.13.1 Business overview
  - 18.1.13.2 Products offered
  - 18.1.13.3 Recent developments
    - 18.1.13.3.1 Deals
- 18.1.14 TECNIC PROCESS EQUIPMENT MANUFACTURING, S.L.
  - 18.1.14.1 Business overview
  - 18.1.14.2 Products offered
  - 18.1.14.3 Recent developments
    - 18.1.14.3.1 Product launches
    - 18.1.14.3.2 Expansions
- 18.1.15 ZACROS CORPORATION
  - 18.1.15.1 Business overview
  - 18.1.15.2 Products offered
18.2 OTHER PLAYERS
- 18.2.1 ADOLF KUHNER AG
- 18.2.2 OMNIBRX BIOTECHNOLOGIES PVT LTD.
- 18.2.3 NEW HORIZON BIOTECHNOLOGY, INC.
- 18.2.4 PBS BIOTECH, INC.
- 18.2.5 BBI-BIOTECH GMBH
- 18.2.6 ABEC, INC.
- 18.2.7 ESCO LIFESCIENCES GROUP
- 18.2.8 DISTEK, INC.
- 18.2.9 SATAKE MULTIMIX CORPORATION
- 18.2.10 CELL CULTURE COMPANY, LLC
- 18.2.11 MICRODIGITAL CO., LTD.
- 18.2.12 BIONET
- 18.2.13 MEISSNER FILTRATION PRODUCTS, INC.
- 18.2.14 SOLIDA BIOTECH GMBH
- 18.2.15 G&G TECHNOLOGIES, INC.
- 18.2.16 PHARMNXT BIOTECH
- 18.2.17 TOFFLON LIFE SCIENCE CO., LTD.
- 18.2.18 SHANGHAI LEPURE BIOTECH CO., LTD.

19 RESEARCH METHODOLOGY

19.1 RESEARCH DATA
- 19.1.1 SECONDARY DATA
  - 19.1.1.1 Key secondary sources
  - 19.1.1.2 Key data from secondary research
- 19.1.2 PRIMARY DATA
  - 19.1.2.1 Key primary participants
  - 19.1.2.2 Breakdown of primary interviews
  - 19.1.2.3 Key data from primary sources
19.2 MARKET SIZE ESTIMATION
- 19.2.1 GLOBAL SINGLE-USE BIOREACTORS MARKET ESTIMATION, 2025
  - 19.2.1.1 Approach 1: Company revenue analysis-based estimation (bottom-up)
  - 19.2.1.2 Approach 2: Primary research
    - 19.2.1.2.1 Key industry insights
  - 19.2.1.3 Approach 3: MnM repository analysis
- 19.2.2 SEGMENTAL MARKET SIZE ESTIMATION, 2025
19.3 MARKET GROWTH RATE PROJECTIONS
19.4 DATA TRIANGULATION
19.5 RESEARCH ASSUMPTIONS
19.6 RESEARCH LIMITATIONS & RISK ASSESSMENT

20 APPENDIX

20.1 DISCUSSION GUIDE
20.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
20.3 CUSTOMIZATION OPTIONS
20.4 RELATED REPORTS
20.5 AUTHOR DETAILS

Product Code: BT 2863

List of Tables

TABLE 1 SINGLE-USE BIOREACTORS MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2 SINGLE-USE BIOREACTORS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
TABLE 3 COMPARISON OF SINGLE-USE AND MULTI-USE BIOREACTORS
TABLE 4 WATER AND ENERGY CONSUMPTION FOR A TYPICAL PROCESS (COMMERCIAL MAB PRODUCTION AT 3 X 2,000 L SCALE)
TABLE 5 EXAMPLES OF ORGANIZATIONS INVOLVED IN SU STANDARDS
TABLE 6 COMPARISON OF SINGLE-USE BIOPROCESS SYSTEM DISPOSAL OPTIONS
TABLE 7 SINGLE-USE BIOREACTORS MARKET: IMPACT OF PORTER'S FIVE FORCES
TABLE 8 SINGLE-USE BIOREACTORS MARKET: ROLE IN ECOSYSTEM
TABLE 9 AVERAGE SELLING PRICE TREND OF KEY SINGLE-USE BIOREACTOR PRODUCTS, BY KEY PLAYER, 2023-2025 (USD)
TABLE 10 AVERAGE SELLING PRICE TREND OF KEY SINGLE-USE BIOREACTOR PRODUCTS, BY REGION, 2023-2025 (USD)
TABLE 11 IMPORT DATA FOR HS CODE 841989, 2021-2025 (USD THOUSAND)
TABLE 12 IMPORT DATA FOR HS CODE 841989, 2021-2025 (UNITS)
TABLE 13 EXPORT DATA FOR HS CODE 841989, 2021-2025 (USD THOUSAND)
TABLE 14 EXPORT DATA FOR HS CODE 841989, 2021-2025 (TONS)
TABLE 15 SINGLE-USE BIOREACTORS MARKET: KEY CONFERENCES & EVENTS, 2026-2027
TABLE 16 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 17 SINGLE-USE BIOREACTORS MARKET: INDICATIVE LIST OF PATENTS, 2026
TABLE 18 CASE STUDIES OF AI IMPLEMENTATION IN SINGLE-USE BIOREACTORS MARKET
TABLE 19 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN SINGLE-USE BIOREACTORS
TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 COMPARATIVE ENVIRONMENTAL PROFILE OF SINGLE-USE AND STAINLESS STEEL BIOPROCESSING PLATFORMS ACROSS KEY SUSTAINABILITY INDICATORS
TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
TABLE 26 KEY BUYING CRITERIA, BY END USER
TABLE 27 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 28 EXAMPLES OF SINGLE-USE BIOREACTOR SYSTEMS
TABLE 29 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY SCALE RANGE, 2024-2031 (USD MILLION)
TABLE 30 SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 31 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 32 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 33 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 34 LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 35 MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 36 GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 37 <=10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 38 NORTH AMERICA: <=10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 39 EUROPE: <=10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 40 ASIA PACIFIC: <=10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 41 LATIN AMERICA: <=10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 42 MIDDLE EAST: <=10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 43 GCC COUNTRIES: <=10 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 44 11-100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 45 NORTH AMERICA: 11-100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 46 EUROPE: 11-100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 47 ASIA PACIFIC: 11-100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 48 LATIN AMERICA: 11-100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 49 MIDDLE EAST: 11-100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 50 GCC COUNTRIES: 11-100 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 51 101-500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 52 NORTH AMERICA: 101-500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 53 EUROPE: 101-500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 54 ASIA PACIFIC: 101-500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 55 LATIN AMERICA: 101-500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 56 MIDDLE EAST: 101-500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 57 GCC COUNTRIES: 101-500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 58 501-1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 59 NORTH AMERICA: 501-1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 60 EUROPE: 501-1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 61 ASIA PACIFIC: 501-1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 62 LATIN AMERICA: 501-1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 63 MIDDLE EAST: 501-1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 64 GCC COUNTRIES: 501-1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 65 >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 66 NORTH AMERICA: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 67 EUROPE: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 68 ASIA PACIFIC: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 69 LATIN AMERICA: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 70 MIDDLE EAST: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 71 GCC COUNTRIES: >1,500 L SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 72 SINGLE-USE BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 73 SINGLE-USE BAGS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 74 NORTH AMERICA: SINGLE-USE BAGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 75 EUROPE: SINGLE-USE BAGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 76 ASIA PACIFIC: SINGLE-USE BAGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 77 LATIN AMERICA: SINGLE-USE BAGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 78 MIDDLE EAST: SINGLE-USE BAGS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 79 GCC COUNTRIES: SINGLE-USE BAGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 80 2D SINGLE-USE BAGS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 81 NORTH AMERICA: 2D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 82 EUROPE: 2D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 83 ASIA PACIFIC: 2D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 84 LATIN AMERICA: 2D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 85 MIDDLE EAST: 2D SINGLE-USE BAGS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 86 GCC COUNTRIES: 2D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 87 3D SINGLE-USE BAGS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 88 NORTH AMERICA: 3D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 89 EUROPE: 3D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 90 ASIA PACIFIC: 3D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 91 LATIN AMERICA: 3D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 92 MIDDLE EAST: 3D SINGLE-USE BAGS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 93 GCC COUNTRIES: 3D SINGLE-USE BAGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 94 SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 95 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 96 EUROPE: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 97 ASIA PACIFIC: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 98 LATIN AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 99 MIDDLE EAST: SINGLE-USE ASSEMBLIES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 100 GCC COUNTRIES: SINGLE-USE ASSEMBLIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 101 OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 102 NORTH AMERICA: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 103 EUROPE: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 104 ASIA PACIFIC: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 105 LATIN AMERICA: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 106 MIDDLE EAST: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 107 GCC COUNTRIES: OTHER SINGLE-USE BIOREACTOR PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 108 SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 109 EXAMPLES OF STIRRED-TANK SINGLE-USE BIOREACTOR SYSTEMS
TABLE 110 STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 111 NORTH AMERICA: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 112 EUROPE: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 113 ASIA PACIFIC: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 114 LATIN AMERICA: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 115 MIDDLE EAST: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 116 GCC COUNTRIES: STIRRED-TANK SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 117 EXAMPLES OF WAVE-INDUCED SINGLE-USE BIOREACTOR SYSTEMS
TABLE 118 WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 119 NORTH AMERICA: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 120 EUROPE: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 121 ASIA PACIFIC: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 122 LATIN AMERICA: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 123 MIDDLE EAST: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 124 GCC COUNTRIES: WAVE-INDUCED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 125 EXAMPLES OF FIXED-BED SINGLE-USE BIOREACTOR SYSTEMS
TABLE 126 FIXED-BED SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 127 NORTH AMERICA: FIXED-BED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 128 EUROPE: FIXED-BED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 129 ASIA PACIFIC: FIXED-BED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 130 LATIN AMERICA: FIXED-BED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 131 MIDDLE EAST: FIXED-BED SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 132 GCC COUNTRIES: FIXED-BED SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 133 BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 134 NORTH AMERICA: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 135 EUROPE: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 136 ASIA PACIFIC: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 137 LATIN AMERICA: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 138 MIDDLE EAST: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 139 GCC COUNTRIES: BUBBLE-COLUMN SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 140 OTHER SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 141 NORTH AMERICA: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 142 EUROPE: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 143 ASIA PACIFIC: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 144 LATIN AMERICA: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 145 MIDDLE EAST: OTHER SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 146 GCC COUNTRIES: OTHER SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 147 SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 148 SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 149 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 150 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 151 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 152 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 153 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 154 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 155 SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY REGION, 2024-2031 (USD MILLION)
TABLE 156 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 157 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 158 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 159 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 160 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY REGION, 2024-2031 (USD MILLION)
TABLE 161 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR VACCINES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 162 SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY REGION, 2024-2031 (USD MILLION)
TABLE 163 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 164 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 165 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 166 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 167 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY REGION, 2024-2031 (USD MILLION)
TABLE 168 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 169 SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY REGION, 2024-2031 (USD MILLION)
TABLE 170 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 171 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 172 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 173 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 174 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY REGION, 2024-2031 (USD MILLION)
TABLE 175 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR THERAPEUTIC PROTEINS & PEPTIDES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 176 SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 177 SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY REGION, 2024-2031 (USD MILLION)
TABLE 178 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 179 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 180 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 181 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 182 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY REGION, 2024-2031 (USD MILLION)
TABLE 183 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR MAMMALIAN CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 184 SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY REGION, 2024-2031 (USD MILLION)
TABLE 185 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 186 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 187 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 188 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 189 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY REGION, 2024-2031 (USD MILLION)
TABLE 190 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 191 SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY REGION, 2024-2031 (USD MILLION)
TABLE 192 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 193 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 194 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 195 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 196 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY REGION, 2024-2031 (USD MILLION)
TABLE 197 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR YEAST CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 198 SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY REGION, 2024-2031 (USD MILLION)
TABLE 199 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 200 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 201 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 202 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 203 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY REGION, 2024-2031 (USD MILLION)
TABLE 204 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR OTHER CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 205 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 206 SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY REGION, 2024-2031 (USD MILLION)
TABLE 207 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 208 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 209 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 210 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 211 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY REGION, 2024-2031 (USD MILLION)
TABLE 212 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR BIOPRODUCTION, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 213 SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 214 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 215 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 216 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 217 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 218 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 219 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR PROCESS DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 220 SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 221 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 222 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 223 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 224 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 225 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 226 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 227 SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 228 SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY REGION, 2024-2031 (USD MILLION)
TABLE 229 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 230 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 231 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 232 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 233 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY REGION, 2024-2031 (USD MILLION)
TABLE 234 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR FED-BATCH PROCESS MODE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 235 SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY REGION, 2024-2031 (USD MILLION)
TABLE 236 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 237 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 238 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 239 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 240 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY REGION, 2024-2031 (USD MILLION)
TABLE 241 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR BATCH PROCESS MODE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 242 SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/CONTINUOUS PROCESS MODE, BY REGION, 2024-2031 (USD MILLION)
TABLE 243 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/CONTINUOUS PROCESS MODE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 244 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/CONTINUOUS PROCESS MODE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 245 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/CONTINUOUS PROCESS MODE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 246 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/ CONTINUOUS PROCESS MODE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 247 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/ CONTINUOUS PROCESS MODE, BY REGION, 2024-2031 (USD MILLION)
TABLE 248 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR PERFUSION/ CONTINUOUS PROCESS MODE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 249 SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 250 SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 251 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 252 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 253 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 254 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 255 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 256 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 257 SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS, BY REGION, 2024-2031 (USD MILLION)
TABLE 258 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 259 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 260 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 261 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 262 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS, BY REGION, 2024-2031 (USD MILLION)
TABLE 263 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR CROS & CDMOS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 264 SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
TABLE 265 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 266 EUROPE: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 267 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 268 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 269 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
TABLE 270 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 271 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 272 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 273 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 274 NORTH AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 275 NORTH AMERICA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 276 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 277 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 278 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 279 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 280 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 281 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 282 NATIONAL INSTITUTES OF HEALTH FUNDING, FY2024-FY2026
TABLE 283 US: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 284 US: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 285 US: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 286 US: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 287 US: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 288 US: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 289 US: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 290 US: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 291 US: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 292 CANADA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 293 CANADA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 294 CANADA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 295 CANADA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 296 CANADA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 297 CANADA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 298 CANADA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 299 CANADA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 300 CANADA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 301 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 302 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 303 EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 304 EUROPE: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 305 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 306 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 307 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 308 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 309 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 310 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 311 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 312 GERMANY: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 313 GERMANY: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 314 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 315 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 316 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 317 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 318 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 319 GERMANY: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 320 UK: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 321 UK: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 322 UK: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 323 UK: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 324 UK: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 325 UK: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 326 UK: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 327 UK: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 328 UK: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 329 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 330 FRANCE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 331 FRANCE: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 332 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 333 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 334 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 335 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 336 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 337 FRANCE: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 338 ITALY: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 339 ITALY: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 340 ITALY: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 341 ITALY: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 342 ITALY: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 343 ITALY: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 344 ITALY: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 345 ITALY: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 346 ITALY: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 347 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 348 SPAIN: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 349 SPAIN: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 350 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 351 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 352 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 353 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 354 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 355 SPAIN: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 356 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 357 REST OF EUROPE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 358 REST OF EUROPE: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 359 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 360 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 361 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 362 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 363 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 364 REST OF EUROPE: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 365 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 366 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 367 ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 368 ASIA PACIFIC: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 369 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 370 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 371 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 372 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 373 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 374 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 375 CHINA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 376 CHINA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 377 CHINA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 378 CHINA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 379 CHINA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 380 CHINA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 381 CHINA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 382 CHINA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 383 CHINA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 384 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 385 SOUTH KOREA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 386 SOUTH KOREA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 387 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 388 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 389 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 390 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 391 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 392 SOUTH KOREA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 393 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 394 JAPAN: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 395 JAPAN: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 396 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 397 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 398 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 399 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 400 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 401 JAPAN: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 402 INDIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 403 INDIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 404 INDIA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 405 INDIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 406 INDIA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 407 INDIA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 408 INDIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 409 INDIA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 410 INDIA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 411 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 412 AUSTRALIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 413 AUSTRALIA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 414 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 415 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 416 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 417 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 418 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 419 AUSTRALIA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 420 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 421 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 422 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 423 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 424 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 425 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 426 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 427 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 428 REST OF ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 429 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 430 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 431 LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 432 LATIN AMERICA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 433 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 434 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 435 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 436 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 437 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 438 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 439 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 440 BRAZIL: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 441 BRAZIL: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 442 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 443 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 444 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 445 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 446 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 447 BRAZIL: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 448 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 449 MEXICO: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 450 MEXICO: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 451 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 452 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 453 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 454 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 455 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 456 MEXICO: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 457 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 458 REST OF LATIN AMERICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 459 REST OF LATIN AMERICA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 460 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 461 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 462 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 463 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 464 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 465 REST OF LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 466 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 467 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 468 MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 469 MIDDLE EAST: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 470 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 471 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 472 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 473 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 474 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 475 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 476 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 477 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 478 GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 479 GCC COUNTRIES: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 480 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 481 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 482 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 483 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 484 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 485 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 486 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 487 SAUDI ARABIA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 488 SAUDI ARABIA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 489 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 490 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 491 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 492 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 493 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 494 SAUDI ARABIA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 495 UAE: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 496 UAE: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 497 UAE: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 498 UAE: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 499 UAE: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 500 UAE: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 501 UAE: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 502 UAE: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 503 UAE: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 504 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 505 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 506 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 507 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 508 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 509 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 510 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 511 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 512 REST OF GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 513 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 514 REST OF MIDDLE EAST: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 515 REST OF MIDDLE EAST: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 516 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 517 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 518 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 519 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 520 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 521 REST OF MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 522 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
TABLE 523 AFRICA: SINGLE-USE BIOREACTOR SYSTEMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 524 AFRICA: SINGLE-USE BIOREACTOR BAGS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 525 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 526 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE, 2024-2031 (USD MILLION)
TABLE 527 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE, 2024-2031 (USD MILLION)
TABLE 528 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 529 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE, 2024-2031 (USD MILLION)
TABLE 530 AFRICA: SINGLE-USE BIOREACTORS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 531 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SINGLE-USE BIOREACTORS MARKET, JANUARY 2023-JULY 2026
TABLE 532 SINGLE-USE BIOREACTORS MARKET: DEGREE OF COMPETITION
TABLE 533 SINGLE-USE BIOREACTORS MARKET: REGION FOOTPRINT
TABLE 534 SINGLE-USE BIOREACTORS MARKET: PRODUCT FOOTPRINT
TABLE 535 SINGLE-USE BIOREACTORS MARKET: TYPE FOOTPRINT
TABLE 536 SINGLE-USE BIOREACTORS MARKET: APPLICATION FOOTPRINT
TABLE 537 SINGLE-USE BIOREACTORS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025
TABLE 538 SINGLE-USE BIOREACTORS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY PRODUCT AND REGION, 2025
TABLE 539 SINGLE-USE BIOREACTORS MARKET: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
TABLE 540 SINGLE-USE BIOREACTORS MARKET: DEALS, JANUARY 2023-JULY 2026
TABLE 541 SINGLE-USE BIOREACTORS MARKET: EXPANSIONS, JANUARY 2023-JULY 2026
TABLE 542 SARTORIUS AG: COMPANY OVERVIEW
TABLE 543 SARTORIUS AG: PRODUCTS OFFERED
TABLE 544 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
TABLE 545 SARTORIUS AG: DEALS, JANUARY 2023-JULY 2026
TABLE 546 SARTORIUS AG: EXPANSIONS, JANUARY 2023-JULY 2026
TABLE 547 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 548 DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 549 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
TABLE 550 DANAHER CORPORATION: DEALS, JANUARY 2023-JULY 2026
TABLE 551 DANAHER CORPORATION: EXPANSIONS, JANUARY 2023-JULY 2026
TABLE 552 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 553 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 554 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
TABLE 555 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023-JULY 2026
TABLE 556 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023-JULY 2026
TABLE 557 MERCK KGAA: COMPANY OVERVIEW
TABLE 558 MERCK KGAA: PRODUCTS OFFERED
TABLE 559 MERCK KGAA: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
TABLE 560 MERCK KGAA: DEALS, JANUARY 2023-JULY 2026
TABLE 561 MERCK KGAA: EXPANSIONS, JANUARY 2023-JULY 2026
TABLE 562 AVANTOR, INC.: COMPANY OVERVIEW
TABLE 563 AVANTOR, INC.: PRODUCTS OFFERED
TABLE 564 AVANTOR, INC.: DEALS, JANUARY 2023-JULY 2026
TABLE 565 AVANTOR, INC.: EXPANSIONS, JANUARY 2023-JULY 2026
TABLE 566 REPLIGEN CORPORATION: COMPANY OVERVIEW
TABLE 567 REPLIGEN CORPORATION: PRODUCTS OFFERED
TABLE 568 REPLIGEN CORPORATION: DEALS, JANUARY 2023-JULY 2026
TABLE 569 REPLIGEN CORPORATION: EXPANSION, JANUARY 2023-JULY 2026
TABLE 570 GETINGE AB: COMPANY OVERVIEW
TABLE 571 GETINGE AB: PRODUCTS OFFERED
TABLE 572 GETINGE AB: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
TABLE 573 GETINGE AB: DEALS, JANUARY 2023-JULY 2026
TABLE 574 GETINGE AB: EXPANSIONS, JANUARY 2023-JULY 2026
TABLE 575 EPPENDORF SE: COMPANY OVERVIEW
TABLE 576 EPPENDORF SE: PRODUCTS OFFERED
TABLE 577 EPPENDORF SE: DEALS, JANUARY 2023-JULY 2026
TABLE 578 EPPENDORF SE: EXPANSIONS, JANUARY 2023-JULY 2026
TABLE 579 PARKER HANNIFIN CORPORATION: COMPANY OVERVIEW
TABLE 580 PARKER HANNIFIN CORPORATION: PRODUCTS OFFERED
TABLE 581 ENTEGRIS: COMPANY OVERVIEW
TABLE 582 ENTEGRIS: PRODUCTS OFFERED
TABLE 583 SAINT-GOBAIN: COMPANY OVERVIEW
TABLE 584 SAINT-GOBAIN: PRODUCTS OFFERED
TABLE 585 SAINT-GOBAIN: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
TABLE 586 SAINT-GOBAIN: EXPANSIONS, JANUARY 2023-JULY 2026
TABLE 587 CORNING INCORPORATED: COMPANY OVERVIEW
TABLE 588 CORNING INCORPORATED: PRODUCTS OFFERED
TABLE 589 LONZA: COMPANY OVERVIEW
TABLE 590 LONZA: PRODUCTS OFFERED
TABLE 591 LONZA: DEALS, JANUARY 2023-JULY 2026
TABLE 592 TECNIC PROCESS EQUIPMENT MANUFACTURING, S.L.: COMPANY OVERVIEW
TABLE 593 TECNIC PROCESS EQUIPMENT MANUFACTURING, S.L.: PRODUCTS OFFERED
TABLE 594 TECNIC PROCESS EQUIPMENT MANUFACTURING, S.L.: PRODUCT LAUNCHES, JANUARY 2023-JULY 2026
TABLE 595 TECNIC PROCESS EQUIPMENT MANUFACTURING, S.L.: EXPANSIONS, JANUARY 2023-JULY 2026
TABLE 596 ZACROS CORPORATION: COMPANY OVERVIEW
TABLE 597 ZACROS CORPORATION: PRODUCTS OFFERED
TABLE 598 ADOLF KUHNER AG: COMPANY OVERVIEW
TABLE 599 OMNIBRX BIOTECHNOLOGIES PVT LTD.: COMPANY OVERVIEW
TABLE 600 NEW HORIZON BIOTECHNOLOGY, INC.: COMPANY OVERVIEW
TABLE 601 PBS BIOTECH, INC.: COMPANY OVERVIEW
TABLE 602 BBI-BIOTECH GMBH: COMPANY OVERVIEW
TABLE 603 ABEC, INC.: COMPANY OVERVIEW
TABLE 604 ESCO LIFESCIENCES GROUP: COMPANY OVERVIEW
TABLE 605 DISTEK, INC.: COMPANY OVERVIEW
TABLE 606 SATAKE MULTIMIX CORPORATION: COMPANY OVERVIEW
TABLE 607 CELL CULTURE COMPANY, LLC: COMPANY OVERVIEW
TABLE 608 MICRODIGITAL CO., LTD.: COMPANY OVERVIEW
TABLE 609 BIONET: COMPANY OVERVIEW
TABLE 610 MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW
TABLE 611 SOLIDA BIOTECH GMBH: COMPANY OVERVIEW
TABLE 612 G&G TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 613 PHARMNXT BIOTECH: COMPANY OVERVIEW
TABLE 614 TOFFLON LIFE SCIENCE CO., LTD.: COMPANY OVERVIEW
TABLE 615 SHANGHAI LEPURE BIOTECH CO., LTD.: COMPANY OVERVIEW
TABLE 616 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 617 RISK ASSESSMENT

List of Figures

FIGURE 1 SINGLE-USE BIOREACTORS MARKET SEGMENTATION & REGIONS COVERED
FIGURE 2 SINGLE-USE BIOREACTORS MARKET: YEARS CONSIDERED
FIGURE 3 MARKET SCENARIO
FIGURE 4 GLOBAL SINGLE-USE BIOREACTORS MARKET, 2024-2031
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN SINGLE-USE BIOREACTORS MARKET, 2023-2026
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF SINGLE-USE BIOREACTORS MARKET
FIGURE 7 HIGH-GROWTH SEGMENTS IN SINGLE-USE BIOREACTORS MARKET, 2026-2031
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN SINGLE-USE BIOREACTORS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 9 INCREASING BIOLOGICS, BIOSIMILARS, VACCINES, AND CELL & GENE THERAPY MANUFACTURING EXPANSION TO PROPEL MARKET GROWTH
FIGURE 10 US AND SINGLE-USE BIOREACTOR SYSTEMS SEGMENT COMMANDED LARGEST MARKET SHARES IN 2025
FIGURE 11 CHINA TO REGISTER HIGHER CAGR DURING FORECAST PERIOD
FIGURE 12 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 13 SINGLE-USE BIOREACTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14 ANNUAL PRODUCTION CAPACITY: SINGLE-PRODUCT FACILITY VS. MULTI-PRODUCT FACILITY
FIGURE 15 COMPARISON BETWEEN SINGLE-PRODUCT AND MULTI-PRODUCT FACILITIES
FIGURE 16 BIOSIMILAR APPROVALS & LAUNCHES, 2015-2025
FIGURE 17 NUMBER OF ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN US/EU, 2012-2025
FIGURE 18 SINGLE-USE BIOREACTORS MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 19 GLOBAL GDP GROWTH, 2020-2030
FIGURE 20 SINGLE-USE BIOREACTORS MARKET: VALUE CHAIN ANALYSIS
FIGURE 21 SINGLE-USE BIOREACTORS MARKET ECOSYSTEM
FIGURE 22 AVERAGE SELLING PRICE TREND OF KEY SINGLE-USE BIOREACTOR PRODUCTS, BY TYPE, 2023-2025 (USD)
FIGURE 23 AVERAGE SELLING PRICE OF KEY SINGLE-USE BIOREACTOR PRODUCTS, BY REGION, 2025 (USD)
FIGURE 24 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
FIGURE 25 TOP APPLICANTS/OWNERS (COMPANIES) FOR SINGLE-USE BIOREACTORS PATENTS, 2015-2025
FIGURE 26 IMPACT OF AI/GEN AI ON SINGLE-USE BIOREACTORS MARKET
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SINGLE-USE BIOREACTOR PRODUCTS
FIGURE 28 KEY BUYING CRITERIA, BY END USER
FIGURE 29 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET SNAPSHOT
FIGURE 30 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET SNAPSHOT
FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN SINGLE-USE BIOREACTORS MARKET, 2021-2025 (USD BILLION)
FIGURE 32 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SINGLE-USE BIOREACTORS MARKET, 2025
FIGURE 33 SINGLE-USE BIOREACTORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 34 SINGLE-USE BIOREACTORS MARKET: COMPANY FOOTPRINT
FIGURE 35 SINGLE-USE BIOREACTORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 36 EV/EBITDA OF KEY VENDORS, 2026
FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2026
FIGURE 38 SINGLE-USE BIOREACTORS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 39 SARTORIUS AG: COMPANY SNAPSHOT (2025)
FIGURE 40 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
FIGURE 42 MERCK KGAA: COMPANY SNAPSHOT (2025)
FIGURE 43 AVANTOR, INC.: COMPANY SNAPSHOT (2025)
FIGURE 44 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 45 GETINGE AB: COMPANY SNAPSHOT (2025)
FIGURE 46 EPPENDORF SE: COMPANY SNAPSHOT (2025)
FIGURE 47 PARKER HANNIFIN CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 48 ENTEGRIS: COMPANY SNAPSHOT (2025)
FIGURE 49 SAINT-GOBAIN: COMPANY SNAPSHOT (2025)
FIGURE 50 CORNING INCORPORATED: COMPANY SNAPSHOT (2025)
FIGURE 51 LONZA: COMPANY SNAPSHOT (2025)
FIGURE 52 ZACROS CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 53 SINGLE-USE BIOREACTORS MARKET: RESEARCH DESIGN
FIGURE 54 SINGLE-USE BIOREACTORS MARKET: BREAKDOWN OF PRIMARIES
FIGURE 55 GLOBAL SINGLE-USE BIOREACTORS MARKET ESTIMATION, 2025
FIGURE 56 SINGLE-USE BIOREACTORS MARKET: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH) (2025)
FIGURE 57 ILLUSTRATIVE EXAMPLE OF SARTORIUS AG: REVENUE ANALYSIS (2025)
FIGURE 58 SINGLE-USE BIOREACTORS MARKET: INSIGHTS FROM PRIMARIES
FIGURE 59 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 60 SINGLE-USE BIOREACTORS MARKET: CAGR PROJECTIONS
FIGURE 61 SINGLE-USE BIOREACTORS MARKET: DATA TRIANGULATION

Single-Use Bioreactors Market by Product, Type (Stirred Tank), Cell Type (Mammalian, Bacterial, Yeast), Molecule (mAbs, Vaccines, CGT), Process Mode, Application, Competition, Region - Global Forecast to 2031

Description

Table of Contents

List of Tables

The primary interviews conducted for this report can be categorized as follows:

The report provides insights into the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 EXECUTIVE SUMMARY

3 PREMIUM INSIGHTS

4 MARKET OVERVIEW

5 INDUSTRY TRENDS

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS

7 SUSTAINABILITY & REGULATORY LANDSCAPE

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

9 SINGLE-USE BIOREACTORS MARKET, BY PRODUCT

10 SINGLE-USE BIOREACTORS MARKET, BY TYPE

11 SINGLE-USE BIOREACTORS MARKET, BY MOLECULE TYPE

12 SINGLE-USE BIOREACTORS MARKET, BY CELL TYPE

13 SINGLE-USE BIOREACTORS MARKET, BY APPLICATION

14 SINGLE-USE BIOREACTORS MARKET, BY PROCESS MODE

15 SINGLE-USE BIOREACTORS MARKET, BY END USER

16 SINGLE-USE BIOREACTORS MARKET, BY REGION

17 COMPETITIVE LANDSCAPE

18 COMPANY PROFILES

19 RESEARCH METHODOLOGY

20 APPENDIX

List of Tables

List of Figures